NasdaqGS:ALMRLife Sciences
Alamar Biosciences (ALMR) Introduced Its NULISAseq Immune 340 Panel
Alamar Biosciences (NasdaqGS: ALMR) announced the launch of its NULISAseq Immune 340 Panel, aimed at profiling hard to measure immune system proteins across multiple disease areas.
The company expanded its partnership with ALZpath to advance blood based diagnostics for Alzheimer's disease using ALZpath's phosphorylated tau 217 (pTau217) antibody.
Management positions the two updates as strengthening Alamar's role in translational research, drug development, and precision medicine...